Photo of Samuel Blackman taken from Day One Biopharmaceuticals/LinkedIn
May 1, 2024, 16:49
Samuel Blackman: As many of you know, I do like to write things
Samuel Blackman, Founder and Head of Research and Development at Day One Biopharmaceuticals, shared on LinkedIn:
“As many of you know, I do like to write things. And on the occasion of our recent approval, I had some thoughts.
It took a while for me to get them out as last week was a whirlwind of emotion and meetings and travel and celebration.
But I finally did. Instead of putting them in print, however, I decided to just say them (warning: this may exceed the MTD of Sam for most people).
Finally, for everyone who sent a lovely note, thank you. I read every single one.”
Proceed to video attached to post.
Source: Samuel Blackman/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08
Nov 13, 2024, 16:02
Nov 13, 2024, 15:56